Even for a puppy, Kat Donatello’s black lab, Austin, was hyperactive. After experimenting with natural supplements on her older dog, Brady, Donatello slipped the puppy a special biscuit.
“It just kind of took the edge off of him,” she said.
The treat contained cannabidiol, better known as CBD, a chemical compound extracted from the marijuana plant.
The CBD supplements were expensive, and options for pet treats were limited, Donatello said.
“So I started spending my winters baking dog biscuits,” she said, adding that she tinkered with the recipe before launching her CBD-laced biscuit company, Austin + Kat, earlier this year.
Along with Therabis and Treatibles, Austin + Kat is one of several cannabidiol-for-dogs businesses that have popped up in the past two years, a time period during which CBD pet product sales doubled in the US, according to data kept by cannabis industry analytics firm MJ Freeway.
It is the newest trend in the US’ booming half-billion dollar animal supplements market, which is expected to grow by more than US$150 million in the next four years.
CBD is one of over 80 active cannabinoid chemicals in marijuana, according to the National Institute on Drug Abuse.
Unlike tetrahydrocannabinol (THC), CBD does not create a euphoric sensation. In other words, these biscuits will not get your dog high, but there is some debate as to what effect the compound has on our furry friends and whether they should be consuming it at all.
Academic research about CBD’s affect on animals is nearly nonexistent, and the US Food and Drug Administration has not approved marijuana use in animals. Despite this, some veterinarians recommend their use, and producers say pet stores are increasingly beginning to carry CBD treats. Treatibles is even in talks to be sold at a big box pet store, though an executive would not reveal which one, as the deal is still pending.
Veterinarians’ views on the supplement vary. When asked about the effectiveness of CBD in dogs, veterinarian Robert Goggs said there is “virtually no evidence in the veterinary literature on this.”
By contrast, veterinarians Robert Silver and Gary Richter recently hosted a course on the cannabis-dedicated learning Web site Green Flower entitled the “Cannabis for Pets Masterclass.”
Contacted by phone, Richter conceded that scholarly literature is lacking.
“A lot of what we’re using is extrapolated data from humans, as well as just real world experience on what works,” he explained.
If it works for humans, he said, it could work for dogs.
In lieu of research, the CBD-for-dogs industry cites supportive veterinarians and customer testimonials as evidence of the products’ effectiveness.
On Treatibles’ Web site, an interview with the owner of mixed-breed pup Shelby shows how the dog, plagued with anxiety and fear, was able to settle down after eating a laced treat.
Human studies have linked CBD to anti-seizure, anti-inflammatory and anti-anxiety effects. In findings presented to the US Senate on International Narcotics Control in June last year, National Institute on Drug Abuse director Nora Volkow said CBD could potentially aid those suffering from Alzheimer’s, stroke, multiple sclerosis and Parkinson’s.
Despite the largely positive feedback in Volkow’s presentation, she warned that additional research on CBD is necessary.
The Drug Enforcement Administration (DEA) agrees and hopes to review further scientific studies on CBD.
CBD is often purchased online, which is technically a violation of US federal law, according to DEA spokesman Russell Baer.
“Extracts or derivatives from the cannabis plant are Schedule I controlled substances — just like the plant itself,” Baer said in an e-mailed statement. “There is widespread illegal distribution of purported CBD products — regardless if they are derived from the marijuana plant or hemp plant,” he added.
Understandably, the DEA’s attention is not on CBD at a time when the US faces an opioid crisis, and sterilized cannabis seeds can be legally used in animal feed mixture.
When asked about the legality of the business, Therabis called it a “complex situation.”
Austin + Kat’s Donatello expressed frustration with the DEA’s position in light of the US Controlled Substances Act and her ability to purchase CBD products at Walmart.com.
Treatibles did not reply to a request for comment.
There is also the matter of ethics.
Humans can verbally express discomfort when trying a new treatment. Dogs cannot.
“If the proper administration of marijuana can truly relieve dogs’ pain, then they should be given the same consideration that humans in pain are given, with regular doses to help reduce their misery,” People for the Ethical Treatment of Animals senior vice president Daphna Nachminovitch said. “But it’s an entirely different matter to amuse oneself by getting the cat drunk or the dog high.”
While the researchers debate what, exactly, CBD can do for Fido, investors are excited by its increasing popularity, which has been buoyed by the US legalization of cannabis (for humans) and increased dialogue about the medicinal properties of marijuana.
Treatibles founder Julianna Carella has seen sales explode “like wildfire” over the past two years.
Therabis has experienced equally explosive growth in its first year of business; since February, the company has seen revenue quadruple, and sales have grown 30 percent month-on-month, according to Joe Hodas, chief marketing officer of the treat brand’s parent company.
Troy Dayton, cofounder of the Arcview Group, an Oakland, California-based investment firm, was a skeptic before he saw the sales numbers.
“If humans are noticing in droves all the different ways where cannabis products can have utility for them, then surely there will be a massive application [for animals],” he said.
Over the past two years, Arcview has been involved in fundraising efforts for two CBD pet-product companies.
Dayton anticipates that additional capital will follow, particularly from investors leery of getting into the recreational cannabis market, which is legally murky.
“There’s a lot of opportunity” in the CBD market, Dayton said.
“I’m not surprised at all that the space is growing,” Carella said. “There’s so many pet owners that would do just about anything to relieve their animals’ suffering.”
STEADY: Prices are to rebound following inventory rebuilding demand, TrendForce said, with Samsung Electronics Co further trimming capacity as it slashes DDR4 lines The contract prices of DRAM chips are to rise by as much as 18 percent sequentially this quarter — the first price upticks in about eight quarters — driven mainly by inventory rebuilding demand for DRAM chips used in mobile devices and PCs, TrendForce Corp (集邦科技) projected yesterday. The price rebound is led by a quarterly increase of mobile DRAM chips, which are to climb between 13 percent and 18 percent quarter-on-quarter this quarter, which has not been seen since the fourth quarter of 2021, the Taipei-based market researcher predicted. Likewise, the price of mainstream PC DDR4 DRAM is expected to bounce
CHINA NOT A FRIEND: ‘Newsflash: Democracy is good for your businesses,’ US Secretary of Commerce Gina Raimondo said as she gave a speech at a national defense forum US Secretary of Commerce Gina Raimondo on Saturday urged lawmakers, Silicon Valley and US allies to stop China from getting semiconductors and cutting-edge technologies key to national security. Speaking at an annual national defense forum in Simi Valley, California, Raimondo called Beijing “the biggest threat we’ve ever had” and stressed that “China is not our friend.” The world’s top two economies are locked in a fierce commercial and geopolitical rivalry, in which her department plays a leading role. In October, Raimondo unveiled a series of restrictions on the export of advanced chips to China, including those used in the development of artificial intelligence
SOLID FOUNDATION: Given its decades of expertise in megatronics, manufacturing and robotics, Japan has the wherewithal to create its own AI, Jensen Huang said Nvidia Corp plans to help build an artificial intelligence (AI) tech-related ecosystem in Japan to meet demand in a country eager to gain an edge in this emerging technology. The US company will seek to partner with Japanese research organizations, companies and start-ups to build factories for AI, Nvidia CEO Jensen Huang (黃仁勳) said yesterday during opening remarks in a meeting with Japanese Minister of Economy, Trade and Industry Yasutoshi Nishimura. The company is to set up an AI research laboratory, and invest in local start-ups and educate the public on using AI, Huang said. Huang earlier this week met with Japanese Prime
A Hong Kong court postponed a court hearing on troubled Chinese property developer Evergrande Group’s (恆大集團) winding-up petition scheduled for yesterday until Jan. 29. Evergrande is trying to win support from its creditors for a plan to restructure more than US$300 billion in debt to stave off liquidation. The company’s lawyer told the court it was requesting an adjournment to “refine” its new debt restructuring plan. The Hong Kong High Court has postponed the hearing over Evergrande’s potential liquidation several times. Judge Linda Chan (陳靜芬) had said in October that yesterday’s hearing would be the last before a decision is handed down. Chan